• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Concord Biotech: Stock Market’s New Biotech entrant ready with IPO
  • National Research Foundation (NRF): facing support and resistance from scientific communities! Why?
  • Biodiversity- preserve or perish
  • Dr Rajesh Gokhale assumes charge as Secretary of Department of Science and Technology
  • Advancing allergy detection and management in India: A pathway to improved health
  • Gujarat govt signs MOUs with 15 companies for ₹2000 cr in a single day
  • Pune biotech firm announces cheaper drug for colorectal cancer
  • Ambiq Propels Remote Healthcare Monitoring Sector Growth with New Ultra-Low Processors
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    May 22, 2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»SARS- CoV2 & COVID-19 Updates»Do not Push COVID vaccine for Children, trial size is laughable, says Experts

Do not Push COVID vaccine for Children, trial size is laughable, says Experts

0
By Biotech Express on November 30, 2021 SARS- CoV2 & COVID-19 Updates

Global evidence available so far has suggested that the Sars CoV-2 virus that causes Covid-19 has infected kids but it hasn’t caused any severity among them. The mortality rate is as low as two children per 10 lakh. However, in India, the government hasn’t released any data (like other COVID data) on the mortality of children due to Covid-19 in both the first and the second waves.

The seroprevalence survey conducted in various parts of the country including Delhi has also shown that 70 per cent to 90 per cent of kids have already been exposed to the virus and they have developed natural antibodies.

Dr Amitav Banerjee, Clinical epidemiologist, In Dr D Y Patil Medical College, Pune, points out physiological as well as epidemiological evidence which suggests that kids don’t need vaccines. “They have very well-developed thymus glands which produce very good T-Cell and memory cell immunity. They also lack ACE-2 receptors on which the spike protein of the virus latches in the lungs,” Dr Banerjee said. He added, “Also, they have got a very high melatonin level that is very protective against the virus. So physiologically they are very well-protected by the nature.” ” , said.

Experts like Dr Sanjay K Rai, Professor, Centre for Community Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi and Dr Jayaprakash Muliyil, who is chairman of the Scientific Advisory Committee of the National Institute of Epidemiology, are of the view that the risk of Adverse Event Following Immunization (AEFI) is very low but it is not zero at all. “In such scenarios, we should look at a comparative picture of risk from Covid-19 as well as AEFI. If the latter outweighs the former, then vaccination is a costly and risky exercise with no benefits,” Dr Rai said.

Dr Muliyil also feels that the death among kids, especially below 12, is almost zero and “there is no reason to vaccinate kids as they are not vulnerable to Covid-19,” he said.

Dr Banerjee seconds the view that the vaccine’s side effect is not negligible. “There has been adverse effect from the vaccine particularly Myocarditis after the launch of vaccinations for children in some countries,” he said. Once the mass vaccination process started, countries reported several types of side effects, including changes to women’s menstrual cycles in the UK and blood clotting from the AstraZeneca (Covishield) vaccine among others. In April 2021, various European countries restricted the use of AstraZeneca (Covishield); it is not recommended for the young, based on safety concerns.

Bhaskaran Raman, a faculty in the Department of Computer Science and Engineering at IIT Bombay, said, “Data from various countries such as the USA, Israel, and Canada show that this risk of Myocarditis to kids from the mRNA vaccine is about 1 in 6000. Considering this, many European countries recently stopped the use of the Moderna vaccine for those under 30,”. Raman has been carrying out a data study of various countries on the impact of vaccination. He said, “It is important to note here that the above risks were not signalled in the initial vaccine trials: the trial size itself was too small to uncover rare risks (32,449 for AstraZeneca/Covishield). That these risks have been found after mass vaccination is deeply concerning.”

He added, “The trial sizes for kids’ vaccines (525: Covaxin, 1000: ZyCov-D), are laughably small, except that this is no laughing matter. Such low trial sizes cannot capture anything but the most obvious risks. Would we discover other risks of Covaxin or ZyCov-D after vaccinating millions of children? This is a very worrying unknown indeed.”

Raman in his data research has found that in the USA, for kids aged 5-14, Covid represents a lower risk than each of the following: flu/pneumonia, drowning, heart disease, homicide, suicide, traffic accidents, and cancer.

“In the context of India, other comparisons are even starker: nearly 9 lakh children die of hunger-related causes every year. Almost 2000 infants die every single day in India, of preventable malnutrition-related causes: infant mortality rate of nearly 3% is about 1000-2000 times more than the risk of Covid death for kids!” Raman said.

 

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

COVID no longer a global health emergency, WHO says

Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?

Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions

Leave A Reply Cancel Reply

Current Issue – July 2023
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Concord Biotech: Stock Market’s New Biotech entrant ready with IPO July 31, 2023
  • National Research Foundation (NRF): facing support and resistance from scientific communities! Why? July 25, 2023
  • Biodiversity- preserve or perish July 24, 2023
  • Dr Rajesh Gokhale assumes charge as Secretary of Department of Science and Technology July 23, 2023
  • Advancing allergy detection and management in India: A pathway to improved health July 23, 2023
  • Gujarat govt signs MOUs with 15 companies for ₹2000 cr in a single day July 22, 2023
  • Pune biotech firm announces cheaper drug for colorectal cancer July 21, 2023
  • Ambiq Propels Remote Healthcare Monitoring Sector Growth with New Ultra-Low Processors July 20, 2023
  • BMJ Open retracted a diabetes paper because it was funded by tobacco company July 19, 2023
  • Indian scientist made First Marwari horse foal through Embryo transfer technology July 12, 2023
  • Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society May 22, 2023
  • FABA holds Conference on Antimicrobial Resistance Stewardship Series May 22, 2023
  • COVID no longer a global health emergency, WHO says May 18, 2023
  • Chemist in India loses seven papers of biology, blames outsourcing of images May 17, 2023
  • Indian Research scholars express frustration over DST’s tweet, plan stir May 16, 2023
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect” September 21, 2022
  • Vaccination, Rising Deaths, And The False Narrative September 20, 2022
  • Guestorial: Genome Mapping Techniques and its Application in Aquaculture September 19, 2022
  • Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’ September 5, 2022
  • Deaths due Covid-19 vaccines should be compensated by vaccine makers: Expert hope on Kerala HC remark August 21, 2022
  • Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions August 20, 2022
  • Anthony Fauci, Controversial US Top-doc FINALLY, To Retire By Year-end August 20, 2022
  • SII’s Cervevac: The new DCGI approved vaccine without published clinical trial results August 20, 2022
  • Pitch your Start-up to National/International Venture Capitalists – first ever opportunity provided to Bio-Start-ups by FABA August 19, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.